Microbial and Human Determinants of the Onset of IBD Flares
NCT05463900 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2023-10-30
Summary
This is a longitudinal, observational study that aims to identify the microbial and human molecular triggers of IBD flares via stool, saliva, and blood metatranscriptomes, whole blood proteome, and collected clinical metadata. This study is direct to participant and will not utilize clinical sites.
Conditions
- Ulcerative Colitis
- Crohn Disease
- Irritable Bowel
- Crohns Disease Aggravated
- Crohn Disease in Remission
Sponsors & Collaborators
-
Viome
lead INDUSTRY
Principal Investigators
-
Momchilo Vuyisich · Viome
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-01
- Primary Completion
- 2025-07-31
- Completion
- 2025-07-31
Countries
- United States
Study Locations
More Related Trials
-
A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD
NCT04079335 ·Status: UNKNOWN
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients
NCT03566407 ·Status: TERMINATED ·Phase: NA
-
Cytokines and Genes in Therapeutic Response in Crohn's Disease
NCT03266471 ·Status: COMPLETED
-
Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease
NCT00790543 ·Status: COMPLETED
-
Study of Inflammatory Markers (VNN1) in Crohn Disease and Ulcerative Colitis.
NCT02304666 ·Status: UNKNOWN ·Phase: NA
-
Fecal Biomarker Study for Patients With Ulcerative Colitis
NCT00780507 ·Status: COMPLETED
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Gene Expression in Inflammatory Bowel Disease
NCT01171872 ·Status: ENROLLING_BY_INVITATION
-
Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)
NCT01349920 ·Status: COMPLETED
-
The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)
NCT04757181 ·Status: COMPLETED ·Phase: NA
-
Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD)
NCT04852666 ·Status: COMPLETED
-
IBD Self-management Website and Home Faecal Calprotectin Monitoring
NCT03671980 ·Status: COMPLETED ·Phase: NA
-
Mucosal Innate Immune Activation in Chronic Intestinal Disorders
NCT03529318 ·Status: WITHDRAWN
-
A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis
NCT04877990 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
NCT07113522 ·Status: RECRUITING ·Phase: PHASE2
-
Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.
NCT07172945 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Stratifying Crohn's Using Biomarker Assessment
NCT04321863 ·Status: UNKNOWN
-
Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel Diseases
NCT02878395 ·Status: UNKNOWN
-
Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success
NCT05702879 ·Status: RECRUITING
-
Study of an Environmental Risk Factor in Crohn's Disease
NCT04960826 ·Status: RECRUITING
-
The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel Disease
NCT05652491 ·Status: WITHDRAWN
-
Predicting IBD Treatment Outcomes With Gut Microbiome Analysis
NCT06453720 ·Status: RECRUITING
-
A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)
NCT05596422 ·Status: COMPLETED
-
Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease
NCT04818892 ·Status: COMPLETED